Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$766K Buy
14,619
+219
+2% +$11.6K 0.04% 450
2026
Q1
$795K Buy
14,400
+1,458
+11% +$79K 0.04% 428
2025
Q4
$635K Buy
+12,942
New +$604K 0.03% 461

Other funds holding GSK

Nations Financial Group's GSK Position: Q2 2026 in Review

Nations Financial Group increased its GSK (GSK) stake by 1.5% in Q2 2026, buying an estimated $11.6K and bringing the position to 14,619 shares worth $766K. The position accounts for 0.04% of the portfolio, ranked #450.

Nations Financial Group first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. The position peaked at $795K in Q1 2026. 296 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Nations Financial Group held 14,619 shares of GSK worth $766K as of Q2 2026.
  • Nations Financial Group bought 219 GSK shares in Q2 2026, an estimated $11.6K.
  • GSK made up 0.04% of Nations Financial Group's portfolio in Q2 2026, its #450 holding.
  • Nations Financial Group first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • Nations Financial Group's GSK position peaked at $795K in Q1 2026.
  • 296 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Nations Financial Group's 13F filing for Q2 2026, filed 23 Jul 2026.